Is this you?
Request access for Virginia Heart with your @virginiaheart.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall79Recruit55Ops85Sponsor89Ther92
Performance (observed)
Historical trials
497
Completed
262
Terminated/Withdrawn
55
Completion rate
83%
Active now
164
Phase 2
102
Phase 3
235
Realized enrollment
479,770
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
14,993
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
1,208
States
Virginia
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Children's Oncology Group; Boston Scientific Corporation; Abbott Medical Devices; SWOG Cancer Research Network; Alliance for Clinical Trials in Oncology
CROs
Clinipace Worldwide; ICON Clinical Research; Medpace, Inc.; MicroConstants; PPD Development, LP
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
oagbale@virginiaheart.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall79
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.